Contribution of LILRB1 polymorphism and HLA-DRB1-shared epitope to rheumatoid arthritis

Inmunología - Tập 30 - Trang 108-114 - 2011
Juan Francisco Delgado De La Poza1, Elisabet Cantó2, César Díaz-Torné3, Beatriz Ferrer Villahoz2, M. Angeles Martínez Carretero1, Marta López1, Carmen Geli3, César Díaz3, José Luis Rodríguez-Sánchez1, Silvia Vidal2
1Immunology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
2Immunology, Institut de Recerca Hospital de Sant Pau, Barcelona, Spain
3Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Tài liệu tham khảo

Wordsworth, 1991, Polygenic susceptibility in rheumatoid arthritis, Ann Rheum Dis, 50, 343, 10.1136/ard.50.6.343 Deighton, 1989, The contribution of HLA to rheumatoid arthritis, Clin Genet, 36, 178, 10.1111/j.1399-0004.1989.tb03185.x Aho, 1986, Acetabular posterior wall fracture. 38 cases followed for 5 years, Acta Orthop Scand, 57, 101, 10.3109/17453678609000878 Silman, 1993, Twin concordance rates for rheumatoid arthritis: results from a nationwide study, Br J Rheumatol, 32, 903, 10.1093/rheumatology/32.10.903 Stastny, 1978, Association of the B-cell alloantigen DRw4 with rheumatoid arthritis, N Engl J Med, 298, 869, 10.1056/NEJM197804202981602 Gregersen, 1987, The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum, 30, 1205, 10.1002/art.1780301102 Gyetvai, 2010, New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies, Rheumatology (Oxford), 49, 25, 10.1093/rheumatology/kep338 Plenge, 2005, Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4, Am J Hum Genet, 77, 1044, 10.1086/498651 Barton, 2001, Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians, Arthritis Rheum, 44, 61, 10.1002/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO;2-Q Kuroki, 2005, Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis, Hum Mol Genet, 14, 2469, 10.1093/hmg/ddi247 Cario, 2000, Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease, Infect Immun, 68, 7010, 10.1128/IAI.68.12.7010-7017.2000 Borges, 1997, A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules, J Immunol, 159, 5192, 10.4049/jimmunol.159.11.5192 Colonna, 1997, A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells, J Exp Med, 186, 1809, 10.1084/jem.186.11.1809 Chapman, 1999, The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18, Immunity, 11, 603, 10.1016/S1074-7613(00)80135-1 Shiroishi, 2003, Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G, Proc Natl Acad Sci USA, 100, 8856, 10.1073/pnas.1431057100 Samaridis, 1997, Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways, Eur J Immunol, 27, 660, 10.1002/eji.1830270313 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 Morante, 2003, DRB1*1446 allele variations in the group-specific annealing sites of common amplification primers, Tissue Antigens, 62, 251, 10.1034/j.1399-0039.2003.00079.x du Montcel, 2005, New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility, Arthritis Rheum, 52, 1063, 10.1002/art.20989 Holoshitz, 2010, The rheumatoid arthritis HLA-DRB1 shared epitope, Curr Opin Rheumatol, 22, 293, 10.1097/BOR.0b013e328336ba63 van der Heijde, 1996, Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability, Baillieres Clin Rheumatol, 10, 435, 10.1016/S0950-3579(96)80043-4 Mori, 2005, Ethnic differences in allele frequency of autoimmune-disease-associated SNPs, J Hum Genet, 50, 264, 10.1007/s10038-005-0246-8 Hughes, 2006, Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis, Ann Rheum Dis, 65, 1213, 10.1136/ard.2005.046797 Valdes, 2007, Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee, Arthritis Rheum, 56, 137, 10.1002/art.22301 Meyer, 1999, HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis, J Rheumatol, 26, 1024 van Gaalen, 2004, Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis, Arthritis Rheum, 50, 2113, 10.1002/art.20316 Vidal, 2002, Molecular analysis of HLA-DRB1 polymorphism in north-east Spain, Eur J Immunogenet, 29, 75, 10.1046/j.0960-7420.2001.00293.x Saji, 1997 Mewar, 2006, Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis, Arthritis Res Ther, 8, R128, 10.1186/ar2017 van der Helm-van Mil, 2005, Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis, Arthritis Res Ther, 7, R949, 10.1186/ar1767 Young, 2008, The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells, Blood, 111, 3090, 10.1182/blood-2007-05-089771 Aractingi, 2001, HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?, Am J Pathol, 159, 71, 10.1016/S0002-9440(10)61675-6 Wiendl, 2005, Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity, Brain, 128, 2689, 10.1093/brain/awh609 Moser, 1998, Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees, Proc Natl Acad Sci USA, 95, 14869, 10.1073/pnas.95.25.14869 Lindqvist, 2000, A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q, J Autoimmun, 14, 169, 10.1006/jaut.1999.0357 Fanger, 1998, The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes, Eur J Immunol, 28, 3423, 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2 Prod’homme, 2007, The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells, J Immunol, 178, 4473, 10.4049/jimmunol.178.7.4473